We are pleased to invite investors and analysts to participate in our virtual event on Wednesday, 16 March 2022, highlighting Roche data presented during the 2022 Muscular Dystrophy Association - MDA -Virtual Clinical and Scientific Conference, from 13th to 16th March.


16:30 – 17:30 CET / 15:30 - 16:30 GMT
11:30 – 12:30 am EDT / 8:30 – 9:30 am PDT

 

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:30 CET on the day of the event.
> click here

 

Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.

 

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

 

A replay of the webcast will be available via > ir.roche.com

 

*privacy notice

 

Best regards,

 
Bruno Eschli
Head of Investor Relations
Gerard Tobin
Investor Relations Officer
 


Roche Investor Relations 
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
 
  
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
 


get the latest news and updates to your inbox.